Medscape4d
Smoldering MS May Warrant Unique Diagnosis, Treatment, and Research Strategies
But because we don’t know what’s driving it, we don’t know what to go after.” The study was supported by Sanofi. Cree is a co ...
FierceBiotech5d
ASH: Sanofi's BTK inhibitor raises platelet levels in 23% of ITP patients in phase 3
Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...